The GLP-1 Revolution: Addressing India’s Unique Obesity Crisis
The Arrival of Generic GLP-1s in India As India grapples with its status as the world’s diabetes capital, a new wave of generic GLP-1 receptor agonists has entered the domestic market, offering a potential turning point for the nation’s complex obesity epidemic. Pharmaceutical manufacturers are rolling out affordable, locally produced versions of semaglutide and similar…